Avalo Therapeutics, Inc. - AVTX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$511.9M
QoQ value delta ($000)
+$141.7M
(+38.28%)
Implied price effect (QoQ)
-17.81%
Shares
Total shares
34,299,550
QoQ shares delta
+13,914,533
(+68.26%)
Total shares held by funds (by quarter)
Market chart (AVTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Early Q2 2026 data: only 129 institutional holders reported so far. More will appear as funds file with the SEC.